Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer

Clinical trial NCT07498959 · RECRUITING

Trial details

NCT number: NCT07498959
Sponsor: Sahlgrenska University Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Testicular Cancer Seminoma Quality of Life De-escalation RPLND

Start date: 2026-03-19
Primary completion: 2031-03-25
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.